Related Experiment Videos

Coronary risk factors in the elderly: their interactions and treatment

Pierugo Carbonin1, Giuseppe Zuccalà, Emanuele Marzetti

  • 1Catholic University of the Sacred Heart, Rome, Italy. pierugo_carbonin@rm.unicatt.it

Insights

Preventive interventions for coronary heart disease (CHD) offer greater absolute risk reduction in older adults despite decreased relative risk. A comprehensive, multidisciplinary approach is essential for effective prevention in this population.

Area of Science:

  • Gerontology and Cardiovascular Medicine
  • Public Health and Preventive Cardiology

Background:

  • Coronary heart disease (CHD) is a leading cause of mortality and disability in older adults.
  • Risk factor impact on CHD may decrease with age, but absolute risk remains high due to increased event rates.

Purpose of the Study:

  • To evaluate the effectiveness and cost-effectiveness of preventive interventions for CHD in older populations.
  • To highlight the necessity of a holistic, multidisciplinary approach for managing CHD risk factors in the elderly.

Main Methods:

  • Analysis of observational studies and randomized trials on CHD prevention in aging populations.
  • Assessment of the impact of interventions on risk factors (e.g., LDL-cholesterol, inflammation) and comorbidities.
  • Consideration of multidimensional patient assessments, including cognitive, affective, and social factors.

Main Results:

  • Preventive interventions yield greater absolute risk reduction in older adults compared to middle-aged individuals.
  • Treatments like statins demonstrate multifaceted benefits, reducing LDL-cholesterol and inflammation markers.
  • Preventive strategies show more favorable cost-effectiveness in older populations.

Conclusions:

  • A comprehensive, multidisciplinary strategy is crucial for managing CHD risk factors in older adults.
  • Integrating behavioral counseling and social support enhances patient compliance and reduces CHD burden.
  • Effective CHD prevention in the elderly requires addressing complex interactions between risk factors and comorbidities.

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...